ClinConnect ClinConnect Logo
Search / Trial NCT07059468

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Stroke Osteoporosis

ClinConnect Summary

This clinical trial is studying how bone strength changes in people who have had a stroke, specifically looking at the differences between the weaker (paralyzed) and stronger limbs. The goal is to understand what factors affect bone health during the weeks and months after a stroke, which could help improve care and prevent bone problems like osteoporosis—a condition where bones become weak and more likely to break.

To join this study, participants need to be between 40 and 65 years old and have had a stroke on one side of the body, confirmed by brain scans (MRI or CT). They should be mentally alert enough to follow study instructions and have stable health. People with other bone or neurological conditions, multiple strokes, or certain diseases that affect bones won’t be able to join. If eligible, participants will be asked to take part in tests that measure bone strength in their limbs. This research is not yet recruiting, but it hopes to provide important information to help stroke patients maintain stronger bones and reduce the risk of fractures in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 40-65 years with a unilateral stroke confirmed by magnetic resonance imaging (MRI) or computed tomography (CT)
  • Patients with a cognitive status sufficient to understand the study instructions (Mini-Mental State Assessment score ≥ 23)
  • Patients with stable medical and psychological status
  • Patients willing to participate in the study
  • Exclusion Criteria:
  • Presence of hip pathologies that may lead to incorrect measurements in bone mineral density (advanced osteophytic coxarthrosis, heterotrophic ossification, internal fixator, etc.)
  • Previous hip, lumbar vertebra fractures (osteoporotic compression fractures)
  • History of multiple strokes
  • History of concomitant neurological diseases other than stroke (Parkinson, multiple sclerosis, myopathy, etc.)
  • History of diseases that may cause secondary osteoporosis (hypogonadism, primary hyperparathyroidism, thyrotoxicosis, malabsorption, etc.)

About Gaziler Physical Medicine And Rehabilitation Education And Research Hospital

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital is a leading institution dedicated to advancing the field of rehabilitation through innovative clinical research and education. Committed to enhancing patient care and outcomes, the hospital integrates cutting-edge research with comprehensive rehabilitation programs. By fostering collaboration among healthcare professionals, researchers, and academic institutions, Gaziler Hospital aims to develop evidence-based practices and innovative therapeutic solutions. With a focus on patient-centered care, the hospital strives to improve the quality of life for individuals with physical impairments and disabilities.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Engin Koyuncu, Prof.

Study Director

SBÜ ANKARA GAZİLER FİZİK TEDAVİ VE REHABİLİTASYON EĞİTİM VE ARAŞTIRMA HASTANESİ

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported